Inspire Investing LLC boosted its position in Tactile Systems Technology, Inc. (NASDAQ:TCMD – Free Report) by 4.3% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 55,904 shares of the company’s stock after buying an additional 2,310 shares during the period. Inspire Investing LLC owned approximately 0.24% of Tactile Systems Technology worth $908,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of TCMD. First Light Asset Management LLC grew its holdings in Tactile Systems Technology by 38.1% during the fourth quarter. First Light Asset Management LLC now owns 2,859,954 shares of the company’s stock worth $40,897,000 after acquiring an additional 788,535 shares during the period. Cadian Capital Management LP purchased a new position in shares of Tactile Systems Technology during the 4th quarter worth approximately $24,954,000. Vanguard Group Inc. raised its position in shares of Tactile Systems Technology by 0.7% during the 3rd quarter. Vanguard Group Inc. now owns 1,370,403 shares of the company’s stock worth $19,254,000 after purchasing an additional 9,863 shares during the last quarter. Wasatch Advisors LP purchased a new stake in Tactile Systems Technology in the 1st quarter valued at approximately $8,687,000. Finally, Walleye Capital LLC acquired a new stake in shares of Tactile Systems Technology during the third quarter valued at $1,860,000. 83.43% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In other Tactile Systems Technology news, CFO Elaine M. Birkemeyer sold 3,041 shares of the business’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $13.68, for a total transaction of $41,600.88. Following the completion of the sale, the chief financial officer now owns 61,295 shares of the company’s stock, valued at $838,515.60. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, CFO Elaine M. Birkemeyer sold 3,041 shares of Tactile Systems Technology stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $13.68, for a total transaction of $41,600.88. Following the transaction, the chief financial officer now owns 61,295 shares in the company, valued at approximately $838,515.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William W. Burke sold 2,500 shares of the stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of $14.06, for a total value of $35,150.00. Following the completion of the sale, the director now owns 25,273 shares of the company’s stock, valued at approximately $355,338.38. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 6,356 shares of company stock valued at $88,462. 0.96% of the stock is currently owned by company insiders.
Tactile Systems Technology Trading Up 2.5 %
Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) last issued its quarterly earnings results on Monday, May 6th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.06. The firm had revenue of $61.09 million during the quarter, compared to analyst estimates of $59.10 million. Tactile Systems Technology had a net margin of 10.19% and a return on equity of 15.88%. As a group, equities analysts predict that Tactile Systems Technology, Inc. will post 0.58 earnings per share for the current year.
Analyst Upgrades and Downgrades
Separately, StockNews.com lowered shares of Tactile Systems Technology from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 9th.
About Tactile Systems Technology
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Recommended Stories
- Five stocks we like better than Tactile Systems Technology
- Quiet Period Expirations Explained
- Financial Giant’s Shares Soar on EPS Beat and Record Asset Levels
- What Are Growth Stocks and Investing in Them
- Stock Rotation is Underway: Here are the Winners Moving Forward
- Trading Stocks: RSI and Why it’s Useful
- Impressive Rally: Eyeing Further Upside for This Financial Stock
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.